Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 1
1950 2
1951 5
1953 1
1954 3
1956 1
1964 2
1973 1
1976 1
1977 1
1984 1
1985 2
1986 2
1987 2
1988 4
1991 6
1992 2
1993 3
1994 4
1995 5
1996 6
1997 9
1998 9
1999 8
2000 9
2001 12
2002 10
2003 10
2004 14
2005 15
2006 11
2007 21
2008 22
2009 26
2010 19
2011 30
2012 27
2013 14
2014 19
2015 17
2016 13
2017 8
2018 11
2019 10
2020 7
2021 13
2022 11
2023 10
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

413 results

Results by year

Filters applied: . Clear all
Page 1
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. Marson A, et al. Among authors: baker ga. Lancet. 2021 Apr 10;397(10282):1375-1386. doi: 10.1016/S0140-6736(21)00246-4. Lancet. 2021. PMID: 33838758 Free PMC article. Clinical Trial.
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. Marson A, et al. Among authors: baker ga. Lancet. 2021 Apr 10;397(10282):1363-1374. doi: 10.1016/S0140-6736(21)00247-6. Lancet. 2021. PMID: 33838757 Free PMC article. Clinical Trial.
Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.
Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD Study Group. Meador KJ, et al. Among authors: baker ga. Lancet Neurol. 2013 Mar;12(3):244-52. doi: 10.1016/S1474-4422(12)70323-X. Epub 2013 Jan 23. Lancet Neurol. 2013. PMID: 23352199 Free PMC article. Clinical Trial.
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.
Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR; SANAD Study group. Marson AG, et al. Among authors: baker ga. Lancet. 2007 Mar 24;369(9566):1016-26. doi: 10.1016/S0140-6736(07)60461-9. Lancet. 2007. PMID: 17382828 Free PMC article. Clinical Trial.
WITHDRAWN: Psychological treatments for epilepsy.
Ramaratnam S, Baker GA, Goldstein LH. Ramaratnam S, et al. Among authors: baker ga. Cochrane Database Syst Rev. 2016 Feb 25;2(2):CD002029. doi: 10.1002/14651858.CD002029.pub4. Cochrane Database Syst Rev. 2016. PMID: 26912119 Free PMC article. Review.
Uniting for global brain health: Where advocacy meets awareness.
Winter SF, Walsh D, Grisold W, Jordan JT, Singhi P, Cross JH, Guekht A, Hawrot T, Destrebecq F, Feigin VL, Kariuki SM, Owolabi MO, Singh G, Dietrich J, Craven A, Amos A, Mehndiratta MM, Secco M, Baker GA, Sofia F. Winter SF, et al. Among authors: baker ga. Epilepsy Behav. 2023 Aug;145:109295. doi: 10.1016/j.yebeh.2023.109295. Epub 2023 Jun 20. Epilepsy Behav. 2023. PMID: 37348407 No abstract available.
Fetal antiepileptic drug exposure and cognitive outcomes.
Bromley RL, Baker GA. Bromley RL, et al. Among authors: baker ga. Seizure. 2017 Jan;44:225-231. doi: 10.1016/j.seizure.2016.10.006. Epub 2016 Oct 14. Seizure. 2017. PMID: 27784632 Free article. Review.
413 results